The Pharmacy Times® Immuno-oncology Resource Center is a comprehensive resource for clinical news and expert insights on treatments that harness the body's immune system to fight cancer.
March 28th 2024
The results displayed a dramatic reduction in the individuals’ tumors within days after single treatment.
Continuing the Conversation in Myelofibrosis: The Role of Managed Care in Supporting Treatment Goals Through Appropriate Use of Emerging Therapies
1.0 Credits / Hematology, Oncology
View More
Caring for Patients With Chronic Graft-versus-Host Disease: The Important Role of Pharmacists on the Cancer Care Team
1.5 Credits / Hematology, Oncology
View More
Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Improving Pharmacists' Knowledge of Endometrial Cancer and Solutions for Equity and Medication Access
1.5 Credits / Endocrinology, Diabetes & Metabolism, Oncology
View More
New Frontiers in the Treatment of Lower-Risk Myelodysplastic Syndromes and the Role of Oncology Pharmacists
1.5 Credit / Hematology, Oncology
View More
Clinical Updates in AML Induction and Maintenance Regimens and the Role of the Specialty Pharmacist
1.5 Credit(s) / Hematology, Oncology
View More
Managed Care Approaches to Improve Outcomes in Frontline Therapy for Advanced Renal Cell Carcinoma
1.0 Credit / Oncology
View More
Demystifying the Details of T-Cell Engaging Bispecific Antibodies: Establishing a Foundation for Oncology Pharmacists
2.0 Credits / Oncology
View More
Continuing the Conversation: A Review of Targeted Therapies for Early-Stage Breast Cancer
0.5 Credit / Oncology, Women’s Health
View More
The Impact of Antibody-Drug Conjugates in Bladder Cancer and Gynecologic Malignancies
1.0 Credit / Oncology
View More
Assessing the Role of Antibody-Drug Conjugates in Breast Cancer Treatment Pathways
1.0 Credit / Oncology
View More
Opportunities to Optimize Treatment of Non-Small Cell Lung Cancer and Gastric Cancers With Antibody-Drug Conjugates
1.0 Credit / Oncology
View More
Exploring the Value of Pharmacist-Led Toxicity Management for New and Emerging Antibody-Drug Conjugates Across Solid Tumors
1.25 Credits / Oncology
View More
Improving Patient Outcomes in TNBC: Immunotherapy, PARP, TROP2, Oh My!
2.0 Credits / Oncology
View More
A Pharmacologic Overview of Antibody-Drug Conjugates
2.0 Credits / Oncology
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Supporting Safe, Effective, and Equitable Access to B-Cell Maturation Antigen (BCMA)-Directed Treatments in Multiple Myeloma: Strategies for Specialty and Managed Care Pharmac...
1.5 Credit / Hematology, Oncology
View More
Empowering Pharmacists to Improve Care for Patients with Myelofibrosis
1.0 Credit / Oncology
View More
Novel Therapeutic Approaches for EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer: An Oncology Pharmacy Perspective
1.0 Credit / Oncology, Pulmonology/Respiratory
View More
Updates and Insights in Managing Anti-Androgen Therapies in Prostate Cancer
1.5 Credits / Oncology, Urology
View More
Improving Safety and Efficacy of Frontline Treatment Regimens in Advanced Hepatocellular Carcinoma
1.0 Credit / Oncology
View More
Exploring the Advancements in BTK Inhibitor Therapy for Mantle Cell Lymphoma and the Growing Impact of Oncology Pharmacists
1.0 Credit / Hematology, Oncology
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Optimizing the Utilization of Targeted Therapies in CLL: Considerations and Insights for the Managed Care Professional
1.5 Credit / Oncology
View More
Advances in the Treatment of Myelofibrosis: Updates and Considerations for Managed Care Professionals
1.0 Credit / Hematology, Oncology
View More
Improving the Delivery of CAR T-Cell Therapy for Multiple Myeloma
1.0 Credit / Oncology
View More
The Challenges of Chemotherapy Drug Shortages: The Oncology Pharmacist’s Perspective and Opportunities for Mitigation
1.0 Credit / Oncology
View More
Preparing for the Use of Multi-Cancer Early Detection Tests: Opportunities for Managed Care Professionals to Expand Cancer Screenings and Implement Early Clinical Intervention
1.5 Credits / Oncology
View More
Optimizing Safety and Utilization of Targeted Therapies in MET- or RET-Altered Non-Small Cell Lung Cancer
1.0 Credit / Oncology
View More
Non-Melanoma Skin Cancers: The Evolution of Treatment With Immune Checkpoint Inhibitors and Its Implications for Oncology Pharmacists
1.0 Credit / Oncology, Dermatology
View More
Pharmacists in the Oncology Setting: Financial and Clinical Impact is Significant
November 3rd 2022In the inpatient acute care setting, oncology pharmacists maximize return on investments of oncology products, produce optimal outcomes, and ensure that quality of care is consistent and safe.
Read More
How Cancer Vaccines Can Educate an Immune Response in Advanced Cancer Patients
October 13th 2022Jeremy Graff, chief scientific officer at IMV, discusses why the development of viable cancer vaccines is a bit more slow-going in comparison to the fast-paced development of COVID-19 vaccines during the pandemic.
Watch
A String of Clinical Pearls for Immunotherapy in Non−Small Cell Lung Cancer
April 26th 2022An expert panel engaged the audience in a live virtual symposium and case discussion on immune checkpoint inhibitors (ICIs) in the first-line treatment of non−small cell lung cancer (NSCLC) at the 2021 ASHP Midyear Clinical Meeting.
Read More